Close

Ignyta's (RXDX) Entrectinib Granted FDA Orphan Drug Designation

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/18/2024

1. LVS
2. TSM
3. SPY
4. NFLX
5. CSX
6. UAL
7. ALK
8. EFX
9. TSLA
10. INFY


Go back to Ignyta's (RXDX) Entrectinib Granted FDA Orphan Drug Designation
IGNYTA (NASDAQ: RXDX) Delayed: 199.92 --0 (-0%)
Previous Close $199.92    52 Week High $15.20 
Open $199.92    52 Week Low $4.15 
Day High $199.92    P/E N/A 
Day Low $199.92    EPS $-0.44 
Volume 602,338